In 2018, Zhang et al. reported that EHMT2 is upregulated in non-small cell lung cancer (NSCLC) to epigenetically restore APC2 functions and then silences the Wnt–β-catenin pathway [23]. This evidence concerns the gene APC2 and non-small cell lung carcinoma.